Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Geiger

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Gut|July 28, 2010
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expressionAlexander R Moschen, Clemens Molnar, Sabine Geiger, et al.
BMC Health Services Research|October 24, 2019
Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic reviewHolger Gothe, Sasa Rajsic, Djurdja Vukicevic, et al.
Oncotarget|November 7, 2019
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastomaLasse Dührsen, Sophie Hartfuß, Daniela Hirsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2014
Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeysDenise Carbonaro Sarracino, Alice F Tarantal, C Chang I Lee, et al.
Wiener Klinische Wochenschrift|September 16, 2021
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter studySabine Geiger-Gritsch, Horst Olschewski, Florian Kocher, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Wiener Klinische Wochenschrift|November 6, 2009
[Cost of illness and health service patterns in Morbus Parkinson in Austria]Sonja von Campenhausen, Yaroslav Winter, Julia Gasser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2019
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHDSabine Geiger, Emrah I Ozay, Ulf Geumann, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 5, 2010
Costs of illness and care in Parkinson's disease: an evaluation in six countriesSonja von Campenhausen, Yaroslav Winter, Antonio Rodrigues e Silva, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Gut|July 28, 2010
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expressionAlexander R Moschen, Clemens Molnar, Sabine Geiger, et al.
BMC Health Services Research|October 24, 2019
Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic reviewHolger Gothe, Sasa Rajsic, Djurdja Vukicevic, et al.
Oncotarget|November 7, 2019
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastomaLasse Dührsen, Sophie Hartfuß, Daniela Hirsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2014
Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeysDenise Carbonaro Sarracino, Alice F Tarantal, C Chang I Lee, et al.
Wiener Klinische Wochenschrift|September 16, 2021
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter studySabine Geiger-Gritsch, Horst Olschewski, Florian Kocher, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Wiener Klinische Wochenschrift|November 6, 2009
[Cost of illness and health service patterns in Morbus Parkinson in Austria]Sonja von Campenhausen, Yaroslav Winter, Julia Gasser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2019
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHDSabine Geiger, Emrah I Ozay, Ulf Geumann, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 5, 2010
Costs of illness and care in Parkinson's disease: an evaluation in six countriesSonja von Campenhausen, Yaroslav Winter, Antonio Rodrigues e Silva, et al.
Pageof 4